Sandusky

UMH PROPERTIES, INC. COMPLETES ACQUISITION OF OHIO MANUFACTURED HOME COMMUNITY

Retrieved on: 
Tuesday, June 1, 2021
UMH Properties, UMH, Sandusky, Ohio, Real estate investment trust, Sandusky, States of the United States, Companies, Ohio

FREEHOLD, NJ, June 01, 2021 (GLOBE NEWSWIRE) -- UMH Properties, Inc. (NYSE: UMH) announced that it closed on the acquisition of a manufactured home community located in Sandusky, Ohio for a total purchase price of approximately $10.3 million.

Key Points: 
  • FREEHOLD, NJ, June 01, 2021 (GLOBE NEWSWIRE) -- UMH Properties, Inc. (NYSE: UMH) announced that it closed on the acquisition of a manufactured home community located in Sandusky, Ohio for a total purchase price of approximately $10.3 million.
  • Ohio has been one of our best performing states and we are pleased to add this community to our portfolio.
  • UMH Properties, Inc., which was organized in 1968, is a public equity REIT that owns and operates 127 manufactured home communities with approximately 24,000 developed homesites.
  • These communities are located in New Jersey, New York, Ohio, Pennsylvania, Tennessee, Indiana, Maryland, Michigan, Alabama and South Carolina.

PAOG Highlights ALKM $15 Million Production Facility In Conjunction With CBD Nutraceutical Plan Targeting $5 Billion Market

Retrieved on: 
Thursday, May 27, 2021
Health sciences, Health, Articles, Food science, Nutraceutical, Nutrition, Pharmacy, Chronic obstructive pulmonary disease, Central Business District, Singapore

PAOG's CBD Nutraceuticals are expected to generate revenue this year, in 2021, while the company continues with its long-term CBD pharmaceutical developments.

Key Points: 
  • PAOG's CBD Nutraceuticals are expected to generate revenue this year, in 2021, while the company continues with its long-term CBD pharmaceutical developments.
  • PAOG plans to develop and distribute its CBD nutraceuticals ALKM as a copacker, and North American Cannabis Holdings, Inc. (OTC Pink: USMJ) as a distributor.
  • The 2020 CBD Nutraceuticals Market had an estimated value of $5.2 Billion and it is expected to reach $16.4 Billion by 2027.
  • The second CBD Nutraceutical under development will be derived from PAOG's ongoing COPD research, targeting the COPD treatment market separately from the pharmaceutical market also targeting COPD treatment.

Unitholders Elect Three Directors to the Cedar Fair Board

Retrieved on: 
Wednesday, May 19, 2021
Retail, General Entertainment, Lodging, Destinations, Women, Travel, Teens, MEN, Children, Restaurant, Bar, Specialty, Family, Vacation, Entertainment, Food, Beverage, Consumer, Cedar Fair, Sandusky, Ohio, Sandusky, Ohio, States of the United States, Midwestern United States

\xe2\x80\x9cDuring the COVID-19 disruption, it became apparent how fortunate we were to have a Board of Directors comprised of very seasoned and highly experienced professionals capable of providing invaluable counsel and strategic thinking that helped successfully navigate such unique and difficult circumstances.

Key Points: 
  • \xe2\x80\x9cDuring the COVID-19 disruption, it became apparent how fortunate we were to have a Board of Directors comprised of very seasoned and highly experienced professionals capable of providing invaluable counsel and strategic thinking that helped successfully navigate such unique and difficult circumstances.
  • We greatly appreciate our unitholders recognizing the value they bring to our organization through today\xe2\x80\x99s reelection of our Class II directors.\xe2\x80\x9d\nCedar Fair Entertainment Company (NYSE: FUN), one of the largest regional amusement-resort operators in the world, is a publicly traded partnership headquartered in Sandusky, Ohio.
  • Cedar Fair\xe2\x80\x99s parks are located in Ohio, California, North Carolina, South Carolina, Virginia, Pennsylvania, Minnesota, Missouri, Michigan, Texas and Toronto, Ontario.
  • The Company also operates an additional theme park in California under a management contract.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210519005837/en/\n'

PAOG Targets International Segment of $5 Billion CBD Nutraceutical Market

Retrieved on: 
Thursday, May 13, 2021
Food science, Nutraceutical, Nutrition, Pharmacy

b'Sandusky, Ohio--(Newsfile Corp. - May 13, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today revealed it will include foreign sales in the planned Q4 launch of its three CBD Nutraceutical Products.\nThe 2020 CBD Nutraceuticals Market had an estimated value of $5.2 Billion and it is expected to reach $16.4 Billion by 2027.\nThat market value represents global sales.

Key Points: 
  • b'Sandusky, Ohio--(Newsfile Corp. - May 13, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today revealed it will include foreign sales in the planned Q4 launch of its three CBD Nutraceutical Products.\nThe 2020 CBD Nutraceuticals Market had an estimated value of $5.2 Billion and it is expected to reach $16.4 Billion by 2027.\nThat market value represents global sales.
  • PAOG management is targeting specific international segments to be included in its Q4 sales launch.
  • PAOG management anticipates a lower market entry expense in the targeted international segments.
  • PAOG management also anticipates the international segments to likely contribute a major portion of its overall CBD Nutraceutical sales.\nLast week, PAOG released a preview of the Company\'s plan to launch a CBD Nutraceuticals line of products.

PAOG Confirms CBD Nutraceutical Q4 Revenue Plans

Retrieved on: 
Tuesday, May 11, 2021
Health sciences, Health, Articles, Food science, Nutraceutical, Nutrition, Pharmacy, CBD, Cannabis, Chronic obstructive pulmonary disease, COPD: Journal of Chronic Obstructive Pulmonary Disease

b'Sandusky, Ohio--(Newsfile Corp. - May 11, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today confirmed plans to introduce three CBD Nutraceutical Products beginning in the fourth quarter of this year, 2021.\nOn Friday, PAOG released a preview of the company\'s plan to launch a CBD Nutraceuticals line of products.

Key Points: 
  • b'Sandusky, Ohio--(Newsfile Corp. - May 11, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today confirmed plans to introduce three CBD Nutraceutical Products beginning in the fourth quarter of this year, 2021.\nOn Friday, PAOG released a preview of the company\'s plan to launch a CBD Nutraceuticals line of products.
  • PAOG\'s CBD Nutraceuticals are expected to generate revenue this year, in 2021, while the company continues with its long-term CBD pharmaceutical developments.\nPAOG is working on the development of a CBD pharmaceutical product under the name RespRx, for the treatment of Chronic Obstructive Pulmonary Disorder (COPD) derived from a patented cannabis extraction method - U.S. Patent No.
  • All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company are forward-looking statements that involve risks and uncertainties.
  • Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above.

PAOG Releases CBD Nutraceutical 2021 Product Launch Preview Highlighting PURA EVERx Partnership, ALKM Co-Packing and USMJ Distribution

Retrieved on: 
Friday, May 7, 2021
Health sciences, Articles, Herbalism, Medicinal plants, Cannabis smoking, Psychoactive drugs, Cannabis, Entheogens, Medical cannabis, OTC Markets Group, Nutraceutical, Effects of cannabis

b'Sandusky, Ohio--(Newsfile Corp. - May 7, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today released a preview of the company\'s plan to launch a CBD Nutraceuticals line of products.

Key Points: 
  • b'Sandusky, Ohio--(Newsfile Corp. - May 7, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today released a preview of the company\'s plan to launch a CBD Nutraceuticals line of products.
  • 9,199,960 entitled "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT.
  • Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above.
  • The Company undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.\n'

PAOG 2021 CBD Nutraceuticals Rollout Preview This Friday

Retrieved on: 
Wednesday, May 5, 2021
Medicinal plants, Psychoactive drugs, Euphoriants, Entheogens, Health sciences, Herbalism, Cannabis smoking, Health, COPD: Journal of Chronic Obstructive Pulmonary Disease, Cannabis, Chronic obstructive pulmonary disease, Medical cannabis

b'Sandusky, Ohio--(Newsfile Corp. - May 5, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today confirmed a CBD Nutraceutical Sales Rollout Presentation scheduled this Friday, May 7, 2021.\nLast year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY).

Key Points: 
  • b'Sandusky, Ohio--(Newsfile Corp. - May 5, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today confirmed a CBD Nutraceutical Sales Rollout Presentation scheduled this Friday, May 7, 2021.\nLast year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY).
  • RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived from a patented cannabis extraction method - U.S. Patent No.
  • 9,199,960 entitled "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT.
  • The Company undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.\n'

PAOG CBD Nutraceuticals to Hit Market This Year

Retrieved on: 
Tuesday, May 4, 2021
Medicinal plants, Psychoactive drugs, Euphoriants, Entheogens, Health sciences, Herbalism, Cannabis smoking, Health, COPD: Journal of Chronic Obstructive Pulmonary Disease, Cannabis, Chronic obstructive pulmonary disease, Medical cannabis

b'Sandusky, Ohio--(Newsfile Corp. - May 4, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today confirmed plans to present the Company\'s CBD Nutraceutical Sales Rollout Plan this Friday, May 7, 2021.\nLast year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY).

Key Points: 
  • b'Sandusky, Ohio--(Newsfile Corp. - May 4, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today confirmed plans to present the Company\'s CBD Nutraceutical Sales Rollout Plan this Friday, May 7, 2021.\nLast year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY).
  • RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived from a patented cannabis extraction method - U.S. Patent No.
  • 9,199,960 entitled, "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT.
  • The Company undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.\n'

PAOG 2021 CBD Nutraceutical Sales Rollout Plan Presentation Scheduled This Friday

Retrieved on: 
Monday, May 3, 2021
Medicinal plants, Psychoactive drugs, Euphoriants, Entheogens, Health sciences, Herbalism, Cannabis smoking, Health, COPD: Journal of Chronic Obstructive Pulmonary Disease, Cannabis, Chronic obstructive pulmonary disease, Medical cannabis

b'Sandusky, Ohio--(Newsfile Corp. - May 3, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today announced plans to present the company\'s CBD Nutraceutical Sales Rollout Plan this Friday, May 7, 2021.\nLast year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY).

Key Points: 
  • b'Sandusky, Ohio--(Newsfile Corp. - May 3, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today announced plans to present the company\'s CBD Nutraceutical Sales Rollout Plan this Friday, May 7, 2021.\nLast year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY).
  • RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived from a patented cannabis extraction method - U.S. Patent No.
  • 9,199,960 entitled "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT.
  • The Company undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.\n'

PAOG Anticipates Boost to CBD Pharmaceutical Research Initiative from Improving Cannabis Legalization Outlook

Retrieved on: 
Wednesday, April 28, 2021
Medicinal plants, Entheogens, Euphoriants, Herbalism, Herbs, Health sciences, Psychoactive drugs, Branches of biology, Cannabis, Medical cannabis, Hemp

PURA Farmersville Hemp Brand project partners also include Alkame Holdings, Inc. (OTC Pink: ALKM) and North American Cannabis Holdings, Inc. (OTC Pink: USMJ).

Key Points: 
  • PURA Farmersville Hemp Brand project partners also include Alkame Holdings, Inc. (OTC Pink: ALKM) and North American Cannabis Holdings, Inc. (OTC Pink: USMJ).
  • "\nPAOG management anticipates the improving cannabis legalization horizon to benefit its ongoing CBD Pharmaceutical Development Program by easing anxiety with research partners and prospective investors that stands in the way of pursuing cannabis development interests.\nLast year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY).
  • RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived from a patented cannabis extraction method - U.S. Patent No.
  • The Company undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.\n'